These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19418933)

  • 1. [Treatment of (unresectable) hepatocellular carcinoma at an intermediate or advanced stage].
    Van Daele D; Belaiche J; Delwaide J; Piront P; De Roover A; Detry O; Honoré P; Polus M
    Rev Med Liege; 2009 Mar; 64(3):140-7. PubMed ID: 19418933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The size of the problem: clinical algorithms.
    Forner A; Bruix J
    Dig Dis; 2013; 31(1):95-103. PubMed ID: 23797130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma.
    Giuliani F; Colucci G
    Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatocellular carcinoma.
    Liccioni A; Reig M; Bruix J
    Dig Dis; 2014; 32(5):554-63. PubMed ID: 25034288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatocellular carcinoma.
    Forner A; Hessheimer AJ; Isabel Real M; Bruix J
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategy for staging and treatment: the BCLC update and future prospects.
    Forner A; Reig ME; de Lope CR; Bruix J
    Semin Liver Dis; 2010 Feb; 30(1):61-74. PubMed ID: 20175034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
    Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U;
    Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.
    Wang JH; Kuo YH; Wang CC; Chen CL; Cheng YF; Hsu HC; Lu SN
    Dig Liver Dis; 2013 Jun; 45(6):510-5. PubMed ID: 23218990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
    Llovet JM; Fuster J; Bruix J;
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
    Gish RG; Finn RS; Marrero JA
    Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.
    Park JW; Koh YH; Kim HB; Kim HY; An S; Choi JI; Woo SM; Nam BH
    J Hepatol; 2012 Jun; 56(6):1336-42. PubMed ID: 22314421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.